Hefu Knife, also known as JC-type focused ultrasound tumor treatment system, is a large-scale medical equipment used for clinical non-invasive "removal" of solid tumors. This equipment involves medicine, biomedical engineering, acoustics, automation control, computers, precision machinery manufacturing and other technologies. Its clinical application has achieved significant therapeutic effects, and formally obtained the State Drug Administration issued a quasi-production license (State Drug Administration equipment [quasi] word 2000 No. 323038).
Low-energy ultrasound is accurately focused on the target tissues by Hai Fu Knife, and the energy is amplified by thousands of times, resulting in high temperature effect, cavitation effect, mechanical effect, and ultrasonic biochemical effect, which makes the tumor tissues coagulatively necrotic, and transiently loses the ability to proliferate, infiltrate, and metastasize, and is ultimately absorbed by the organism.
Advanced concepts, innovative practices, medical-industrial integration, perfect design, and system optimization have made the HEFU knife truly the world's first high-intensity focused ultrasound tumor treatment system for non-invasive treatment of tumors outside the body. Its development and clinical application have enabled the local treatment of tumors to move from invasive surgery or interventional therapy into the cutting-edge field of non-invasive treatment.
Since the introduction of Hafu knife in 1999, the hospitals using this equipment include: Churchill Hospital of the University of Oxford, the Second Affiliated Hospital of Chongqing Medical University, the Fourth Affiliated Hospital of Huaxi Medical University in Sichuan, Beijing San07 Hospital, Jiangsu Provincial Cancer Hospital, Peking University Clinical Cancer Hospital, the First People's Hospital of Guangzhou, Shandong Provincial Tumor Hospital, the Tumor Hospital affiliated with Sun Yat-sen University, the Hospital Affiliated to Qinghai Medical College, Guangdong Nongcheng Central Hospital, Shandong Provincial Tumor Hospital, the Affiliated Hospital of Shandong Provincial Medical College, and so on. Guangdong Agricultural Pleasure Center Hospital, Shandong Province Qianfoshan Hospital, Zibo Third People's Hospital, West China Hospital of Sichuan University, Chongqing Three Gorges Central Hospital, Beijing Hospital of the Ministry of Health, Fudan University Medical College Affiliated Tumor Hospital, Haikou People's Hospital and so on. More than 2000 cases of tumor patients have been treated
Indications: liver cancer, kidney cancer, bladder cancer, breast cancer, pelvic tumors, soft tissue sarcoma, malignant bone tumors, retroperitoneal tumors, pancreatic cancer, and uterine fibroids and other solid tumors, but also applicable to the treatment of pain relief for advanced malignant tumors.